JPMorgan cuts Monday.com to Neutral on slowing growth

JPMorgan downgraded Monday.com to Neutral from Overweight and set a December 2027 price target of $87, versus the prior $90 target, citing slowing new ARR growth and customer-acquisition challenges. The stock closed at $79.05, down 5.5%, and fell another 2.6% premarket. JPMorgan expects longer SMB sales cycles, disruption from July's 20% workforce reduction, and limited near-term financial benefit from AI: AI generated 17% of Q2 new ARR but represented less than 1% of total recurring revenue.

Analysis

MNDY's issue is not simply slower growth; it is a deteriorating acquisition funnel in the customer cohort that historically supports efficient expansion. Longer SMB decision cycles raise CAC and defer revenue recognition, while the workforce reduction risks weakening sales coverage and implementation capacity precisely when incumbents are bundling AI functionality into existing seats. This creates a negative operating-leverage setup over the next 1-3 quarters: modest net-new ARR misses can pressure both growth estimates and the premium multiple assigned to a previously durable SaaS compounder.

The competitive read-through is more constructive for bundled workflow vendors with enterprise distribution—MSFT, CRM, NOW and ASAN—than for standalone collaboration software. Frontier-model experimentation may initially delay software budgets rather than displace work-management tools outright, but it weakens MNDY's ability to monetize AI as a separate SKU. The more relevant signal is whether AI improves conversion or expansion in the >$100k cohort; absent that evidence, AI remains a product-cost and go-to-market burden rather than an earnings catalyst.

Consensus may overreact to a single analyst downgrade given the stock's recent decline and relatively stable existing-customer spend. However, a valuation floor is difficult to establish while forward ARR visibility is falling and the July restructuring has not yet flowed through reported sales execution. Near term, the asymmetry remains lower on any guide-down; over 6-18 months, stabilization in enterprise expansion and restructuring-driven margin gains could create a recovery case, but that requires evidence rather than a multiple-based call.

Falsification for the bearish view: sequential improvement in net-new ARR, reacceleration in sub-$50k customer adds, and retention returning above 110% by the next two earnings reports. A material enterprise AI conversion metric or an upward FY revenue/FCF-margin revision would also challenge the thesis.

Key Decisions for Investors

• Maintain or initiate a 1-3 month underweight/short MNDY versus long NOW or MSFT, sized modestly ahead of the next earnings print. The pair isolates standalone-SaaS acquisition risk from broad software-beta; cover if MNDY reports sequential net-new ARR acceleration and retention above 110%.
• For defined-risk exposure, consider MNDY put spreads expiring just after the next earnings date, using strikes roughly 5-15% below spot. The trade targets a guidance-reset gap while limiting losses if restructuring margins or enterprise bookings surprise positively.
• Do not treat the current valuation as a long entry until management discloses conversion, attach rate, or expansion evidence for AI products and down-market pipeline stabilization. Set an alert for FY revenue guidance reduction or billings/deferred-revenue deceleration; either would strengthen the short thesis.
• Watch ASAN as a sympathetic read-through rather than an automatic short: similar SMB/work-management exposure makes it vulnerable to prolonged budget deferrals, but its relative valuation and cash runway must be checked before establishing a pair.